153 related articles for article (PubMed ID: 16158614)
1. [Improved outcome with sirolimus-cyclosporine regimen in high-risk renal transplant recipients].
Podder H; Forgács B; Csapó Z; Kahan B
Orv Hetil; 2005 Jul; 146(31):1641-6. PubMed ID: 16158614
[TBL] [Abstract][Full Text] [Related]
2. Improved renal function in sirolimus-treated renal transplant patients after early cyclosporine elimination.
Gonwa TA; Hricik DE; Brinker K; Grinyo JM; Schena FP;
Transplantation; 2002 Dec; 74(11):1560-7. PubMed ID: 12490789
[TBL] [Abstract][Full Text] [Related]
3. Sirolimus improves the two-year outcome of renal allografts in African-American patients.
Podder H; Podbielski J; Hussein I; Katz S; Van Buren C; Kahan BD
Transpl Int; 2001 Jun; 14(3):135-42. PubMed ID: 11499902
[TBL] [Abstract][Full Text] [Related]
4. Sirolimus reduces the incidence of acute rejection episodes despite lower cyclosporine doses in caucasian recipients of mismatched primary renal allografts: a phase II trial. Rapamune Study Group.
Kahan BD; Julian BA; Pescovitz MD; Vanrenterghem Y; Neylan J
Transplantation; 1999 Nov; 68(10):1526-32. PubMed ID: 10589950
[TBL] [Abstract][Full Text] [Related]
5. Immunosuppressive effects and safety of a sirolimus/cyclosporine combination regimen for renal transplantation.
Kahan BD; Podbielski J; Napoli KL; Katz SM; Meier-Kriesche HU; Van Buren CT
Transplantation; 1998 Oct; 66(8):1040-6. PubMed ID: 9808489
[TBL] [Abstract][Full Text] [Related]
6. [Effectiveness and safety of conversion therapy with the combination of sirolimus with low dose cyclosporine in renal transplantation recipients: a five-year clinical observation].
Zhu L; Ding T; Wang XX; Lin ZB; Chen G
Zhonghua Yi Xue Za Zhi; 2016 May; 96(20):1556-61. PubMed ID: 27266681
[TBL] [Abstract][Full Text] [Related]
7. Better actual 10-year renal transplant outcomes of 80% reduced cyclosporine exposure with sirolimus base therapy compared with full cyclosporine exposure without or with concomittant sirolimus treatment.
Pliszczynski J; Kahan BD
Transplant Proc; 2011 Dec; 43(10):3657-68. PubMed ID: 22172822
[TBL] [Abstract][Full Text] [Related]
8. Effect of sirolimus in combination with low-dose cyclosporine and steroids on acute renal allograft rejection.
Tsai MK; Chueh SC; Hu RH; Lee PH
J Formos Med Assoc; 2003 Feb; 102(2):91-6. PubMed ID: 12709737
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study. The Rapamune US Study Group.
Kahan BD
Lancet; 2000 Jul; 356(9225):194-202. PubMed ID: 10963197
[TBL] [Abstract][Full Text] [Related]
10. Individualization of immunosuppressive therapy: I. Sirolimus improves outcomes in African-American renal transplant recipients.
Podder H; Kahan BD
Transplant Proc; 2005 Nov; 37(9):3723-6. PubMed ID: 16386518
[TBL] [Abstract][Full Text] [Related]
11. Cyclosporine elimination in the presence of TOR inhibitors: effects on renal function, acute rejection, and safety.
Velosa JA; Larson TS; Gloor JM; Stegall MD
Am J Kidney Dis; 2001 Oct; 38(4 Suppl 2):S3-S10. PubMed ID: 11583938
[TBL] [Abstract][Full Text] [Related]
12. Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients.
Kreis H; Cisterne JM; Land W; Wramner L; Squifflet JP; Abramowicz D; Campistol JM; Morales JM; Grinyo JM; Mourad G; Berthoux FC; Brattström C; Lebranchu Y; Vialtel P
Transplantation; 2000 Apr; 69(7):1252-60. PubMed ID: 10798738
[TBL] [Abstract][Full Text] [Related]
13. Comparing an early corticosteroid/late calcineurin-free immunosuppression protocol to a sirolimus-, cyclosporine A-, and prednisone-based regimen for pancreas-kidney transplantation.
Knight RJ; Podder H; Kerman RH; Lawless A; Katz SM; Van Buren CT; Gaber AO; Kahan BD
Transplantation; 2010 Mar; 89(6):727-32. PubMed ID: 20195219
[TBL] [Abstract][Full Text] [Related]
14. Clinical and cost-effectiveness of newer immunosuppressive regimens in renal transplantation: a systematic review and modelling study.
Woodroffe R; Yao GL; Meads C; Bayliss S; Ready A; Raftery J; Taylor RS
Health Technol Assess; 2005 May; 9(21):1-179, iii-iv. PubMed ID: 15899149
[TBL] [Abstract][Full Text] [Related]
15. An open-label randomized trial of the safety and efficacy of sirolimus vs. azathioprine in living related renal allograft recipients receiving cyclosporine and prednisone combination.
Machado PG; Felipe CR; Hanzawa NM; Park SI; Garcia R; Alfieri F; Franco M; Silva HT; Medina-Pestana JO
Clin Transplant; 2004 Feb; 18(1):28-38. PubMed ID: 15108768
[TBL] [Abstract][Full Text] [Related]
16. Concentration-controlled use of sirolimus associated with reduced exposure of cyclosporine in black recipients of primarily living renal allograft donors: 12-month results.
Ferreira AN; Machado PG; Felipe CR; Motegi SA; Hosaka BH; Tanaka MK; Kamura LA; Park SI; Garcia R; Franco M; Alfieri F; Casarini DE; Tedesco-Silva H; Medina-Pestana JO
Clin Transplant; 2005 Oct; 19(5):607-15. PubMed ID: 16146551
[TBL] [Abstract][Full Text] [Related]
17. Racial differences in renal transplantation after immunosuppression with tacrolimus versus cyclosporine. FK506 Kidney Transplant Study Group.
Neylan JF
Transplantation; 1998 Feb; 65(4):515-23. PubMed ID: 9500626
[TBL] [Abstract][Full Text] [Related]
18. Decreased acute rejection and improved renal allograft survival using sirolimus and low-dose calcineurin inhibitors without induction therapy.
Tsai MK; Wu FL; Lai IR; Lee CY; Hu RH; Lee PH
Int J Artif Organs; 2009 Jun; 32(6):371-80. PubMed ID: 19670189
[TBL] [Abstract][Full Text] [Related]
19. The effect of Daclizumab in a high-risk renal transplant population.
Meier-Kriesche HU; Kaza H; Palekar SS; Friedman GS; Mulgaonkar SP; Ojo AO; Kaplan B
Clin Transplant; 2000 Oct; 14(5):509-13. PubMed ID: 11048998
[TBL] [Abstract][Full Text] [Related]
20. [Lymphocele and kidney transplantation].
Langer R; Tóth A; Máthé Z; Remport A; Járay J; Kahan BD
Orv Hetil; 2007 Aug; 148(31):1475-80. PubMed ID: 17656338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
